Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:12 pm Sale | 2024-12-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Lind Global Fund II LP | 0 0.000% | -44,500 (Position Closed) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | JANE STREET GROUP, LLC | 38,349 6.600% | 38,349 (New Position) | Filing History |
| 2024-12-04 1:29 pm Sale | 2024-11-30 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | AdvisorShares Trust | 20,543 4.710% | -131,901 (-86.52%) | Filing History |
| 2024-11-25 3:37 pm Purchase | 2024-11-14 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Weber Mark | 46,480 10.700% | 46,480 (New Position) | Filing History |
| 2024-11-14 7:32 pm Purchase | 2024-09-30 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Lind Global Fund II LP | 44,500 9.900% | 44,500 (New Position) | Filing History |
| 2024-11-05 1:46 pm Purchase | 2024-10-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ | AdvisorShares Trust | 152,444 34.960% | 152,444 (New Position) | Filing History |
| 2024-02-06 5:26 pm Purchase | 2024-01-30 | 13G | Seelos Therapeutics, Inc. SEEL | Lind Global Fund II LP | 11,022 9.900% | 11,022 (New Position) | Filing History |
| 2023-02-09 11:32 am Sale | 2022-12-30 | 13G | Seelos Therapeutics, Inc. SEEL | The Vanguard Group | 1,306 4.680% | -34 (-2.52%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Seelos Therapeutics, Inc. SEEL | BlackRock Inc. BLK | 463 1.700% | -1,246 (-72.88%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | The Vanguard Group | 1,340 5.030% | 611 (+83.81%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | BlackRock Inc. BLK | 1,709 6.400% | 1,709 (New Position) | Filing History |
| 2021-02-10 11:52 am Purchase | 2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | The Vanguard Group | 729 5.240% | 729 (New Position) | Filing History |
| 2021-01-15 4:11 pm Unchanged | 2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | LIGAND PHARMACEUTICALS INC LGND | 579 4.100% | 0 (Unchanged) | Filing History |
| 2021-01-11 4:02 pm Sale | 2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | Phoenixus AG | 0 0.000% | -521 (Position Closed) | Filing History |